Subscribe To
ETON / 4 Biotech Penny Stocks to Watch With New Catalysts
ETON News
By GlobeNewsWire
October 30, 2023
Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023
DEER PARK, Ill., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), an innovative pharmaceutical company focused on developi more_horizontal
By Zacks Investment Research
September 12, 2023
Here's Why 'Trend' Investors Would Love Betting on Eton Pharmaceuticals, Inc. (ETON)
Eton Pharmaceuticals, Inc. (ETON) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently o more_horizontal
By Seeking Alpha
September 11, 2023
Eton Pharmaceuticals: Fading The Rally
Eton Pharmaceuticals, Inc. is a small specialty pharmaceutical company whose main product ALKINDI SPRINKLE is gaining market share. The stock has doub more_horizontal
By GlobeNewsWire
August 23, 2023
Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
DEER PARK, Ill., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developin more_horizontal
By Zacks Investment Research
August 16, 2023
Eton Pharmaceuticals, Inc. (ETON) Hits Fresh High: Is There Still Room to Run?
Eton Pharmaceuticals, Inc. (ETON) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundament more_horizontal
By InvestorPlace
August 11, 2023
Why Is Eton Pharmaceuticals (ETON) Stock Up 30% Today?
Eton Pharmaceuticals (NASDAQ: ETON ) stock is soaring following the release of its earnings report for the second quarter of 2023! The big new exciti more_horizontal
By Seeking Alpha
August 10, 2023
Eton Pharmaceuticals, Inc. (ETON) Q2 2023 Earnings Call Transcript
Eton Pharmaceuticals, Inc. (NASDAQ:ETON ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants David Krempa - Chief Busine more_horizontal
By Zacks Investment Research
August 10, 2023
Eton Pharmaceuticals, Inc. (ETON) Tops Q2 Earnings and Revenue Estimates
Eton Pharmaceuticals, Inc. (ETON) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of a loss of $0.09 per sha more_horizontal